Do you have an industry comp for that? PCYC was acquired for Imbruvica in 2015 for $21B. At the time Imbruvica was slated for $5B/year in 2020, approved in 50 countries and was in 13 phase 3 trials.
And this is coming for a guy who thinks we will be bought out for $8-30/share ($1B-4B), not some ihub hater. I just don't see any data that supports $15B-30B as a reasonable buyout number.
Go IPIX!
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.